Skin Carotenoid Response to a High-Carotenoid Juice in Children: A Randomized Clinical Trial

Insights

Consuming carotenoid-rich juice significantly boosted skin carotenoid levels in children aged 5-17 over 8 weeks. This juice provides carotenoids comparable to cooked carrots, enhancing nutritional status.

Area of Science:

  • Nutrition Science
  • Dermatology
  • Pediatrics

Background:

  • Previous research indicates increased serum carotenoid levels in children following carotenoid supplementation.
  • This study investigates the dose-response relationship between carotenoid intake and changes in skin carotenoid status in children.

Purpose of the Study:

  • To determine the effect of a specific dose of carotenoid-rich juice on skin carotenoid status in children.
  • To establish a dose-response relationship for carotenoid intake and its impact on skin carotenoid levels.

Main Methods:

  • A randomized controlled trial involving 58 children aged 5-17 years.
  • Participants were assigned to high-dose, low-dose carotenoid juice, or placebo groups for 8 weeks.
  • Skin carotenoid levels were measured bi-weekly using resonance Raman spectroscopy.

Main Results:

  • Both high-dose and low-dose groups showed significant increases in skin carotenoid status (P <0.001).
  • Significant changes were observed as early as Week 2 in the supplemented groups.
  • The placebo group exhibited no statistically significant change in skin carotenoid levels.

Conclusions:

  • Daily consumption of 30-120 mL of carotenoid-rich juice effectively increases skin carotenoid status in children.
  • The carotenoid dosage in the juice is equivalent to 23-92g of cooked carrots.
  • This intervention offers a practical method to improve carotenoid levels in pediatric populations.
Abstract

Related Concept Videos

Changes in Skin Color: Clinical Perspectives01:14

Changes in Skin Color: Clinical Perspectives

The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
4.2K
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
210
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
762
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
341
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
378
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
804